Literature DB >> 2195989

Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

J E van Dam1, A Fleer, H Snippe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2195989     DOI： 10.1007/bf02388078

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN： 0003-6072            Impact factor:   2.271


× No keyword cloud information.
  388 in total

1.  Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  H J Jennings; R Roy; A Gamian
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Effect of human airway lysozyme on the in vitro growth of type I Streptococcus pneumoniae.

Authors:  J Jacquot; E Puchelle; J M Zahm; G Beck; M C Plotkowski
Journal:  Eur J Respir Dis       Date:  1987-10

3.  Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.

Authors:  C Lue; A Tarkowski; J Mestecky
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

4.  Synthesis of a trisaccharide component of the capsular polysaccharide of Streptococcus pneumoniae type 19F.

Authors:  T Sugawara; K Igarashi
Journal:  Carbohydr Res       Date:  1988-02-01       Impact factor: 2.104

5.  Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. I. Isolation of oligosaccharides from acid and from enzymatic hydrolysates of S3 and S8.

Authors:  J H Campbell; A M Pappenheimer
Journal:  Immunochemistry       Date:  1966-05

Review 6.  Vaccines against encapsulated bacteria: a global agenda.

Authors:  J M Griffiss; M A Apicella; B Greenwood; P H Mäkelä
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children.

Authors:  I D Riley; D Lehmann; M P Alpers; T F Marshall; H Gratten; D Smith
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

8.  Effect of culture conditions on the structure of Streptococcus pneumoniae type 19A(57) capsular polysaccharide.

Authors:  C J Lee; B A Fraser; R A Boykins; J P Li
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3.

Authors:  H Snippe; J E van Dam; A J van Houte; J M Willers; J P Kamerling; J F Vliegenthart
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy.

Authors:  P A Drew; W N Nieuwhof; A R Clarkson; A J Woodroffe
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330
View more
  44 in total

1.  Characterization of the type 8 capsular gene cluster of Streptococcus pneumoniae.

Authors:  R Muñoz; M Mollerach; R López; E García
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19.

Authors:  J K Morona; R Morona; J C Paton
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

3.  Antibody-enhanced pneumococcal adherence requires IgA1 protease.

Authors:  Jeffrey N Weiser; Deborah Bae; Claudine Fasching; Ronald W Scamurra; Adam J Ratner; Edward N Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

4.  Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents.

Authors:  C Sibold; J Wang; J Henrichsen; R Hakenbeck
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

5.  Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor.

Authors:  Robert T Cartee; W Thomas Forsee; Janet Yother
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

6.  Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

Authors:  D O Chaffin; L M Mentele; C E Rubens
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

7.  Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence.

Authors:  Radha Gupta; Jun Yang; Yimin Dong; Edwin Swiatlo; Jing-Ren Zhang; Dennis W Metzger; Guangchun Bai
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

8.  Recovery of Streptococcus iniae from diseased fish previously vaccinated with a streptococcus vaccine.

Authors:  G Bachrach; A Zlotkin; A Hurvitz; D L Evans; A Eldar
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

9.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

10.  Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E.

Authors:  David B A James; Kanupriya Gupta; Jocelyn R Hauser; Janet Yother
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.